{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T16:24:47Z","timestamp":1793118287349,"version":"4.5.0"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100012524","name":"American Lebanese Syrian Associated Charities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012524","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virchows Arch"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00428-025-04324-x","type":"journal-article","created":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:52:03Z","timestamp":1762001523000},"page":"1329-1336","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["SOX11 is frequently expressed in ETV6::NTRK3-rearranged infantile fibrosarcoma and congenital mesoblastic nephroma"],"prefix":"10.1007","volume":"487","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8597-5074","authenticated-orcid":false,"given":"Faizan","family":"Malik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katelyn S.","family":"Provine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selene C.","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Santiago","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina A.","family":"Tucker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Costabile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Barresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Rullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Alaggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,1]]},"reference":[{"key":"4324_CR1","unstructured":"Knezevich SR, Garnett MJ, Pysher TJ, et al (1998) ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma Cancer Res 58:5046\u20135048"},{"key":"4324_CR2","volume-title":"Soft tissue and bone tumours","author":"WHO Classification of Tumours Editorial Board","year":"2020","unstructured":"WHO Classification of Tumours Editorial Board (2020) Soft tissue and bone tumours, vol 3, 5th edn. International Agency for Research on Cancer, Lyon","edition":"5"},{"key":"4324_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/his.14443","volume":"80","author":"JL Davis","year":"2022","unstructured":"Davis JL, Al-Ibraheemi A, Rudzinski ER et al (2022) Mesenchymal neoplasms with NTRK and other kinase gene alterations. Histopathology 80:4\u201318. https:\/\/doi.org\/10.1111\/his.14443","journal-title":"Histopathology"},{"key":"4324_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1097\/PAS.0000000000001062","volume":"42","author":"ER Rudzinski","year":"2018","unstructured":"Rudzinski ER, Lockwood CM, Stohr BA et al (2018) Pan-Trk immunohistochemistry identifies NTRK rearrangements in pediatric mesenchymal tumors. Am J Surg Pathol 42:927\u2013935. https:\/\/doi.org\/10.1097\/PAS.0000000000001062","journal-title":"Am J Surg Pathol"},{"key":"4324_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2022.100083","volume":"36","author":"N Kojima","year":"2023","unstructured":"Kojima N, Mori T, Motoi T et al (2023) Frequent CD30 expression in an emerging group of mesenchymal tumors with NTRK, BRAF, RAF1, or RET fusions. Mod Pathol 36:100083. https:\/\/doi.org\/10.1016\/j.modpat.2022.100083","journal-title":"Mod Pathol"},{"key":"4324_CR6","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1111\/his.13666","volume":"73","author":"YP Hung","year":"2018","unstructured":"Hung YP, Fletcher CDM, Hornick JL (2018) Evaluation of pan-TRK immunohistochemistry in infantile fibrosarcoma, lipofibromatosis-like neural tumour and histological mimics. Histopathology 73:634\u2013644. https:\/\/doi.org\/10.1111\/his.13666","journal-title":"Histopathology"},{"key":"4324_CR7","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080823","author":"J Seok","year":"2021","unstructured":"Seok J, Gil M, Dayem AA et al (2021) Multi-omics analysis of SOX4, SOX11, and SOX12 expression and the associated pathways in human cancers. J Pers Med. https:\/\/doi.org\/10.3390\/jpm11080823","journal-title":"J Pers Med"},{"key":"4324_CR8","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/bs.ctdb.2019.01.007","volume":"133","author":"V Lefebvre","year":"2019","unstructured":"Lefebvre V (2019) Roles and regulation of SOX transcription factors in skeletogenesis. Curr Top Dev Biol 133:171\u2013193. https:\/\/doi.org\/10.1016\/bs.ctdb.2019.01.007","journal-title":"Curr Top Dev Biol"},{"key":"4324_CR9","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-017-0598-1","volume":"19","author":"S Bea","year":"2017","unstructured":"Bea S, Amador V (2017) Role of SOX11 and genetic events cooperating with cyclin D1 in mantle cell lymphoma. Curr Oncol Rep 19:43. https:\/\/doi.org\/10.1007\/s11912-017-0598-1","journal-title":"Curr Oncol Rep"},{"key":"4324_CR10","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.3324\/haematol.2009.008474","volume":"94","author":"M Dictor","year":"2009","unstructured":"Dictor M, Ek S, Sundberg M et al (2009) Strong lymphoid nuclear expression of SOX11 transcription factor defines lymphoblastic neoplasms, mantle cell lymphoma and Burkitt\u2019s lymphoma. Haematologica 94:1563\u20131568. https:\/\/doi.org\/10.3324\/haematol.2009.008474","journal-title":"Haematologica"},{"key":"4324_CR11","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/his.13757","volume":"74","author":"S Xu","year":"2019","unstructured":"Xu S, Dong Y, Huo Z et al (2019) SOX11: a potentially useful marker in surgical pathology: a systematic analysis of SOX11 expression in epithelial and non-epithelial tumours. Histopathology 74:391\u2013405. https:\/\/doi.org\/10.1111\/his.13757","journal-title":"Histopathology"},{"key":"4324_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.anndiagpath.2025.152447","volume":"75","author":"E Tasar Kapakli","year":"2025","unstructured":"Tasar Kapakli E, Pekmezci M, Katipoglu K et al (2025) The diagnostic utility of SOX11 immunohistochemical expression in malignant peripheral nerve sheath tumors and their potential mimickers. Ann Diagn Pathol 75:152447. https:\/\/doi.org\/10.1016\/j.anndiagpath.2025.152447","journal-title":"Ann Diagn Pathol"},{"issue":"Suppl 1","key":"4324_CR13","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.1007\/s00428-025-04179-2","volume":"487","author":"EVS Rullo","year":"2025","unstructured":"Rullo EVS, Barresi S, Stracuzzi A, Scuderi S, Milano GM, Bisogno G, Costabile V, Alaggio R (2025) Comprehensive analysis of gene expression profiles in paediatric myofibroblastic neoplasms. Virchows Arch 487(Suppl 1):S18. https:\/\/doi.org\/10.1007\/s00428-025-04179-2","journal-title":"Virchows Arch"},{"key":"4324_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.modpat.2023.100387","volume":"37","author":"S Rossi","year":"2024","unstructured":"Rossi S, Barresi S, Colafati GS et al (2024) Patz1-rearranged tumors of the central nervous system: characterization of a pediatric series of seven cases. Mod Pathol 37:100387. https:\/\/doi.org\/10.1016\/j.modpat.2023.100387","journal-title":"Mod Pathol"},{"key":"4324_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.18556","volume":"28","author":"Y Liu","year":"2024","unstructured":"Liu Y, Cao P, Xiao L et al (2024) Hypomethylation-associated Sox11 upregulation promotes oncogenesis via the PI3K\/AKT pathway in OLP-associated OSCC. J Cell Mol Med 28:e18556. https:\/\/doi.org\/10.1111\/jcmm.18556","journal-title":"J Cell Mol Med"},{"key":"4324_CR16","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/onc.2011.323","volume":"31","author":"CE Tognon","year":"2012","unstructured":"Tognon CE, Martin MJ, Moradian A et al (2012) A tripartite complex composed of ETV6-NTRK3, IRS1 and IGF1R is required for ETV6-NTRK3-mediated membrane localization and transformation. Oncogene 31:1334\u20131340. https:\/\/doi.org\/10.1038\/onc.2011.323","journal-title":"Oncogene"},{"key":"4324_CR17","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/s41571-018-0113-0","volume":"15","author":"E Cocco","year":"2018","unstructured":"Cocco E, Scaltriti M, Drilon A (2018) NTRK fusion-positive cancers and TRK inhibitor therapy. Nat Rev Clin Oncol 15:731\u2013747. https:\/\/doi.org\/10.1038\/s41571-018-0113-0","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Virchows Archiv"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00428-025-04324-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00428-025-04324-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:06:30Z","timestamp":1767060390000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00428-025-04324-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,1]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["4324"],"URL":"https:\/\/doi.org\/10.1007\/s00428-025-04324-x","relation":{},"ISSN":["0945-6317","1432-2307"],"issn-type":[{"value":"0945-6317","type":"print"},{"value":"1432-2307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,1]]},"assertion":[{"value":"18 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}